- All > Quality and Safety: Medicines > Counterfeit Medicines
- All > Quality and Safety: Medicines > Quality Assurance
- All > WHO Prequalification of Medical Products > WHO-UNICEF-UN Project
(2013; 11 pages)
The second meeting of the Member State Mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products was held on 28 and 29 November 2013 in Geneva.
The Mechanism considered and adopted the non-exhaustive list of actions, activities and behaviours that result in SSFFC medical products, as contained in the report of the Open-ended Working Group to Identify the Actions, Activities and Behaviours that result in SSFFC medical products (see Annex 1). The Mechanism emphasized that the scope of the Member State Mechanism excludes trade and intellectual property considerations, in accordance with paragraph 4 of World Health Assembly resolution WHA65.19.
The Mechanism reviewed the report of the Steering Committee of the Member State Mechanism on SSFFC and adopted the Steering Committee’s suggestions for finalizing the work plan. The work plan is attached, as amended by the Mechanism, in Annex 2...